Suppr超能文献

相似文献

1
Macrophages promote cyst growth in polycystic kidney disease.
J Am Soc Nephrol. 2011 Oct;22(10):1809-14. doi: 10.1681/ASN.2011010084. Epub 2011 Sep 15.
2
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol. 2018 Oct;29(10):2471-2481. doi: 10.1681/ASN.2018050518. Epub 2018 Sep 12.
3
Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in -Deficient Mice.
J Am Soc Nephrol. 2018 Sep;29(9):2310-2325. doi: 10.1681/ASN.2018010074. Epub 2018 Jul 24.
4
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
Cell Death Dis. 2021 Oct 14;12(10):947. doi: 10.1038/s41419-021-04248-9.
5
Macrophages promote polycystic kidney disease progression.
Kidney Int. 2013 May;83(5):855-64. doi: 10.1038/ki.2012.446. Epub 2013 Feb 20.
6
Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol. 2020 May;31(5):1035-1049. doi: 10.1681/ASN.2019090959. Epub 2020 Apr 1.
7
Interferon Regulatory Factor-5 in Resident Macrophage Promotes Polycystic Kidney Disease.
Kidney360. 2020 Mar;1(3):179-190. doi: 10.34067/KID.0001052019. Epub 2020 Mar 26.
8
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
J Clin Invest. 2015 Jun;125(6):2399-412. doi: 10.1172/JCI80467. Epub 2015 May 11.
9
TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol. 2021 Aug;32(8):1913-1932. doi: 10.1681/ASN.2020071094. Epub 2021 Jun 21.
10
Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
J Am Soc Nephrol. 2024 Apr 1;35(4):398-409. doi: 10.1681/ASN.0000000000000309. Epub 2024 Jan 23.

引用本文的文献

1
Wheat-Based Protein Slows Disease Progression in Pkd1 Knockout Mice.
Function (Oxf). 2025 Aug 1;6(4). doi: 10.1093/function/zqaf026.
2
Association of thrombomodulin with the severity of chronic kidney disease: a cross-sectional study.
BMC Nephrol. 2025 May 30;26(1):268. doi: 10.1186/s12882-025-04200-5.
5
Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era.
Int J Mol Sci. 2025 Jan 28;26(3):1121. doi: 10.3390/ijms26031121.
6
Physiologic mechanisms underlying polycystic kidney disease.
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
7
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
9
Intestinal barrier function declines during polycystic kidney disease progression.
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.
10
Adamts1 and Cyst Expansion in Polycystic Kidney Disease.
J Am Soc Nephrol. 2025 Apr 1;36(4):559-570. doi: 10.1681/ASN.0000000557. Epub 2024 Nov 8.

本文引用的文献

1
Distinct macrophage phenotypes contribute to kidney injury and repair.
J Am Soc Nephrol. 2011 Feb;22(2):317-26. doi: 10.1681/ASN.2009060615.
2
Macrophages and immunologic inflammation of the kidney.
Semin Nephrol. 2010 May;30(3):234-54. doi: 10.1016/j.semnephrol.2010.03.003.
3
Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD.
J Am Soc Nephrol. 2010 Aug;21(8):1275-80. doi: 10.1681/ASN.2009121224. Epub 2010 May 20.
4
Molecular advances in autosomal dominant polycystic kidney disease.
Adv Chronic Kidney Dis. 2010 Mar;17(2):118-30. doi: 10.1053/j.ackd.2010.01.002.
5
Loss of oriented cell division does not initiate cyst formation.
J Am Soc Nephrol. 2010 Feb;21(2):295-302. doi: 10.1681/ASN.2009060603. Epub 2009 Dec 3.
6
Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.
J Immunol. 2009 Nov 15;183(10):6733-43. doi: 10.4049/jimmunol.0901473. Epub 2009 Oct 28.
7
Autosomal dominant polycystic kidney disease: the last 3 years.
Kidney Int. 2009 Jul;76(2):149-68. doi: 10.1038/ki.2009.128. Epub 2009 May 20.
8
Advances in the pathogenesis and treatment of polycystic kidney disease.
Curr Opin Nephrol Hypertens. 2009 Mar;18(2):99-106. doi: 10.1097/MNH.0b013e3283262ab0.
9
Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.
Kidney Int. 2008 Nov;74(10):1310-1318. doi: 10.1038/ki.2008.395. Epub 2008 Aug 13.
10
Polycystic kidney disease.
Annu Rev Med. 2009;60:321-37. doi: 10.1146/annurev.med.60.101707.125712.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验